NGM Biopharmaceuticals (NASDAQ: NGM)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of NGM Biopharmaceuticals (NASDAQ: NGM) through any online brokerage.
The latest price target for NGM Biopharmaceuticals (NASDAQ: NGM) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 29.00 expecting NGM to rise to within 12 months (a possible 103.37% upside). 5 analyst firms have reported ratings in the last year.
The stock price for NGM Biopharmaceuticals (NASDAQ: NGM) is $14.26 last updated July 6, 2022, 8:00 PM UTC.
There are no upcoming dividends for NGM Biopharmaceuticals.
NGM Biopharmaceuticals’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for NGM Biopharmaceuticals.
NGM Biopharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.